If a drug class is reported as present, the test will report the specific drug present from the drug class at no additional charge. (Classes include ARUP test codes 3005225, 3005226, 3005227, 3005228, 3005229, 3005230, 3005231, 3005232, 3005233, 3005234, 3005235, 3005236, 3005237, 3005238, or 3005239.)
Specimen Preparation
Transport 4 mL urine. (Min: 2 mL)
Storage/Transport Temperature
Refrigerated.
Performing Lab
Reference Laboratory
Performed
Mon, Fri
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.
Ordering Recommendations
Use to detect drug exposure from among a targeted list of prescriptions, over-the-counter medications, and illicit drugs; for a complete list of drugs and drug metabolites detected, refer to Additional Technical Information. Not recommended to determine medication compliance or to assess for undisclosed drug/substance use in the context of pain management, substance use disorder treatment, or any other pharmacotherapies involving controlled substances.
Synonyms
Multiple Drug Analysis
Tox Screen Urine
Carisoprodol Screen with Reflex Confirmation
Urine Drug Screen
Drug Analysis
Comprehensive drug screen
general toxicology
Tox Screen
Methodology
Qualitative Liquid Chromatography-Tandem Mass Spectrometry
The qualitative drug panel can detect 127 drugs and drug metabolites by LC-MS/MS. The absence of expected drug(s) and/or drug metabolite(s) may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the test can detect a drug or metabolite varies within a drug class. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
This assay is for medical purposes only; not valid for forensic use.
For a complete list of drugs and drug metabolites detected, refer to Additional Technical Information.
If a drug class is reported as present, the test will report the specific drug present from the drug class at no additional charge. (Classes include ARUP test codes 3005225, 3005226, 3005227, 3005228, 3005229, 3005230, 3005231, 3005232, 3005233, 3005234, 3005235, 3005236, 3005237, 3005238, or 3005239.)
Specimen Preparation
Transport 4 mL urine. (Min: 2 mL)
Storage/Transport Temperature
Refrigerated.
Performing Lab
Reference Laboratory
Performed
Mon, Fri
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.
Ordering
Ordering Recommendations
Use to detect drug exposure from among a targeted list of prescriptions, over-the-counter medications, and illicit drugs; for a complete list of drugs and drug metabolites detected, refer to Additional Technical Information. Not recommended to determine medication compliance or to assess for undisclosed drug/substance use in the context of pain management, substance use disorder treatment, or any other pharmacotherapies involving controlled substances.
Synonyms
Multiple Drug Analysis
Tox Screen Urine
Carisoprodol Screen with Reflex Confirmation
Urine Drug Screen
Drug Analysis
Comprehensive drug screen
general toxicology
Tox Screen
Methodology
Qualitative Liquid Chromatography-Tandem Mass Spectrometry
The qualitative drug panel can detect 127 drugs and drug metabolites by LC-MS/MS. The absence of expected drug(s) and/or drug metabolite(s) may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the test can detect a drug or metabolite varies within a drug class. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
This assay is for medical purposes only; not valid for forensic use.
For a complete list of drugs and drug metabolites detected, refer to Additional Technical Information.
